photo credit: International Medical Corps
No More Epidemics International Advisory Committee is comprised of 17 high level individuals, representing multiple companies, organizations, and sectors. The International Advisory Committee meets quarterly to provide advice and support in effort to inform the campaign’s strategic direction.
Nancy A. Aossey
President and CEO of International Medical Corps
Nancy A. Aossey is President and CEO of International Medical Corps, a preeminent first responder delivering medical relief and training programs in areas hardest-hit by war, natural disaster, disease and displacement. Aossey joined International Medical Corps as its startup CEO, shortly after its founding in 1984. She scaled the organization from a handful of employees to more than 7,000 staff and thousands of volunteers today working on the frontlines of crises including: wars in Syria, Iraq, Yemen, Libya, Afghanistan, and Pakistan; ongoing conflicts in Somalia and South Sudan; the earthquakes in Nepal, Haiti and Japan; and the Ebola outbreak in West Africa, where International Medical Corps trained health workers, provided treatment to Ebola patients, and assisted in ending the outbreak. She has transformed International Medical Corps into one of the largest humanitarian organizations delivering more than $2.2 billion in assistance, health services, and training to tens of millions of people in nearly 70 countries.
Aossey serves on the Board of Directors of the Pacific Council on International Policy; Her Majesty Queen Rania Al-Abdullah’s Jordan River Foundation/USA; the Ronald Reagan UCLA Medical Center, and the Advisory Board of the RAND Center for Middle East Public Policy. Elected by her peers, Aossey served as Chair of the Board of InterAction for three years, the United States’ largest coalition of organizations working in international development, refugee assistance, and disaster relief. She is a member of the Council on Foreign Relations, the Young Presidents’ Organization, and the Chief Executives Organization. She has testified numerous times before Congress, briefed the White House, and is frequently interviewed by major media on humanitarian issues. Her awards include the Goldman Sachs 100 Most Intriguing Entrepreneurs; the Young Presidents’ Organization’s Global Humanitarian Award, as well as its Legacy Award; and the Los Angeles Business Journal’s Leadership Excellence Award and Non-Profit CEO of the Year Award. In recognition of her humanitarian contributions, she was awarded the UCSF Medal, and she also accepted the UC Berkeley Public Health Organizational Hero Award. A resident of Santa Monica, California, Aossey was born and raised in Cedar Rapids, Iowa, and holds a BA, an MBA, and an honorary doctorate from the University of Northern Iowa.
Director, US Agency for International Development’s Global Health Security and Development Unit
Dr. Dennis Carroll currently serves as the Director of the US Agency for International Development’s (USAID) Global Health Security and Development Unit. In this position Dr. Carroll is responsible for providing strategic and operational leadership for the Agency’s programs addressing new and emerging disease threats. Dr. Carroll also serves as USAID’s Special Representative for Global Health Security.
Dr. Carroll was initially detailed to USAID from the US Centers for Disease Control and Prevention as a senior public health advisor in 1991. In 1995 he was named the Agency’s Senior Infectious Diseases advisor, responsible for overseeing the Agency’s programs in malaria, tuberculosis, antimicrobial resistance, disease surveillance, as well as neglected and emerging infectious diseases. In this capacity, Dr. Carroll was directly involved in the development and introduction of a range of new technologies for disease prevention and control, including: community-based delivery of treatment of onchocerciasis, rapid diagnostics for malaria, new treatment therapies for drug resistant malaria, intermittent therapy for pregnant women and “long-lasting” insecticide treated bednets for prevention of malaria. He was responsible for the initial design and development of the President’s Malaria Initiative. Dr. Carroll officially left CDC and joined USAID in 2005 when he assumed responsibility for leading the USAID response to the spread of avian influenza.
Dr. Carroll has a doctorate in biomedical research with a special focus in tropical infectious diseases from the University of Massachusetts at Amherst. He was a Research Scientist at Cold Spring Harbor Laboratory where he studied the molecular mechanics of viral infection. Dr. Carroll has received awards from both CDC and USAID, including the 2006 USAID Science and Technology Award for his work on malaria and avian influenza, and the 2008 Administrator’s Management Innovation Award for his management of the Agency’s Avian and Pandemic Influenza program.
President, EcoHealth Alliance
Dr. Peter Daszak is President of EcoHealth Alliance, a US-based organization that conducts research and outreach programs on global health, conservation, and international development. Dr. Daszak’s research has been instrumental in identifying and predicting the impact of emerging diseases across the globe. His achievements include identifying the bat origin of SARS, and the underlying drivers of both Nipah and Hendra virus emergence. He confirmed the first case of a species extinction due to disease, and identified chytridiomycosis as the cause of amphibian declines around the globe. He is one of the founders of the field of conservation medicine and has been instrumental in the growth of EcoHealth, One Health and now Planetary Health.
A fundamental part of Dr. Daszak’s work on disease ecology is directed by the conviction that disease outbreaks are not just predictable, but preventable. This approach is informed by a perspective on emerging infectious disease research that sees problems of human and animal disease as intimately linked—exacerbated by ecological change. With this in mind, he led the research that produced the first ever global emerging disease ‘hotspots’ map to determine where in the world viruses with pandemic potential were most likely to emerge, and developed a strategy to identify just how many of those viruses currently exist.
Dr. Daszak is a member and Chair-elect of the National Academy of Sciences, Engineering and Medicine’s Forum on Microbial Threats. He is a member of the NRC Advisory Committee to the US Global Change Research Program, and has advised the Director for Medical Preparedness Policy on the White House National Security Staff on global health issues. He is a regular advisor to WHO, OIE and FAO, and is actively involved in the WHO Expert group on Public Health Emergency Disease Prioritization. Dr. Daszak won the 2000 CSIRO medal for collaborative research on the discovery of amphibian chytridiomycosis, is the EcoHealth Alliance institutional lead for USAID-EPT-PREDICT, is on the Editorial Board of Conservation Biology, One Health, and Transactions of the Royal Society of Tropical Medicine & Hygiene, and is Editor-in-Chief of the journal Ecohealth. He has authored over 300 scientific papers, and his work has been the focus of extensive media coverage, ranging from press articles in The New York Times, The Wall Street Journal, The Economist, The Washington Post, US News & World Report, and broadcast appearances on 60 Minutes, CNN, ABC, NPR’s Talk of the Nation, Morning Edition, and Fresh Air with Terry Gross.
Independent Advisor in Viral Vaccinology
Dr. José Esparza, MD, PhD, is an internationally recognized expert in viral vaccinology and is currently an independent advisor in the field. From 2004 to 2014, Dr. Esparza was with The Bill & Melinda Gates Foundation in Seattle, WA, first as Senior Advisor on HIV Vaccines and subsequently as Senior Advisor on Global Health (Vaccines). From 1986 to 2004, Dr. Esparza worked with WHO and UNAIDS, in Geneva, Switzerland, where he became a global leader in the field of HIV vaccines. From 1974 to 1986, he was with the Venezuelan Institute of Scientific Research, where he became the Chairman of the Center of Microbiology and Cell Biology. He is a member of the Venezuelan Academy of Medicine and has received numerous international honors. Dr. Esparza is author of over 180 publications in medical virology, HIV/AIDS and vaccinology. He has served on multiple advisory committees around the world. In 2016, he was the President of the Global Virus Network.
Associate Fellow, Centre on Global Health Security
Ilona Kickbusch is adjunct professor at the Graduate Institute of International and Development Studies, Geneva and director of the Global Health Programme. She advises organizations, government agencies and the private sector on policies and strategies to promote health at the national, European and international level. She has published widely and is a member of a number of advisory boards in both the academic and the health policy arena. She has received numerous awards and served as the Adelaide Thinker in Residence at the invitation of the premier of South Australia. She has also launched a think‐tank initiative, Global Health Europe: A Platform for European Engagement in Global Health and the Consortium for Global Health Diplomacy.
Professor Kickbusch has worked with the World Health Organization, at both regional and global level, where she initiated the Ottawa Charter for Health Promotion and a range of ‘settings ‘projects’ including Healthy Cities. From 1998 – 2003 she joined Yale University as the head of the global health division, where she contributed to shaping the field of global health and headed a major Fulbright programme. She is a political scientist with a PhD from the University of Konstanz, Germany.
Assistant Director-General, Health Systems and Innovation, World Health Organization
Dr. Marie-Paule Kieny was appointed WHO Assistant Director-General for Health Systems and Innovation in November 2012. Dr. Kieny was WHO Assistant Director-General for Innovation, Information, Evidence and Research from October 2010-November 2012. Prior to this, Dr. Kieny directed the WHO Initiative for Vaccine Research since its inception in 2001. Major successes under her leadership were the development and licensing of new vaccines against meningitis, and against pandemic influenza in developing countries through pioneering the transfer of technology and know-how.
Ann Marie Kimball
Senior Consulting Fellow, Chatham House
Dr. Ann Marie Kimball, MD, MPH, FACMP, is a physician and epidemiologist and Senior Consulting Fellow at Chatham House. At Chatham House she leads a number of programs including the new Global Health Fellows Leadership program for West Africa and the collaboration with CORDS for development of West African Network for Infectious Disease Surveillance (WANIDS). She served as technical and strategic lead for The Bill and Melinda Gates Foundation surveillance strategy formation as senior program officer with the foundation.
Prior to Gates, she served as professor of epidemiology at the University of Washington School of Public Health where she is now emerita. At UW, Dr. Kimball founded and directed the APEC Emerging Infections Network, and led research and training programs in Peru and Thailand. She was awarded a Fulbright New Century Scholars and is a Guggenheim Scholar. She is the author ofRisky Trade: Infectious Diseases in an Era of Global Trade, has served on numerous IOM panels, and is extensively published. She is a fellow in the American College of Preventive Medicine.
Director, Communications and Partnerships Group, United Nations Office for Project Services
Mr. Lidén brings vast institutional experience in communications and health communications in emergency situations. After working as a journalist in Africa and Asia, he headed communications at the World Health Organization from 1999 to 2003. From 2003 to 2012, he was the Communications Director for the Global Fund to Fight AIDS, Tuberculosis and Malaria. He is currently the Director of Communications and Partnership Group at UNOPS. Mr. Lidén sits on the No More Epidemics International Advisory Board in his own personal capacity.
Professor of Epidemiology and Disease Ecology and Executive Director, One Health Institute, UC Davis School of Veterinary Medicine
Dr. Jonna Mazet, DVM, MPVM, PhD, is a Professor of Epidemiology and Disease Ecology and Executive Director of the One Health Institute in the UC Davis School of Veterinary Medicine, where she focuses on global health problem solving, especially for emerging infectious disease and conservation challenges. Dr. Mazet is active in international One Health research programs, most notably in relation to disease transmission among wildlife, domestic animals, and people and the ecological drivers of disease emergence. Currently, she is the Global Director of a $175 million viral emergence early warning project, named PREDICT, that has been developed with the US Agency for International Development’s (USAID) Emerging Pandemic Threats Program. She was elected to the US National Academy of Medicine in 2013 in recognition of her successful and innovative approach to emerging environmental and global health threats.
President & Chief Executive Officer, Save the Children
Carolyn Miles is President & Chief Executive Officer of Save the Children, an organization that gives children in the United States and around the world a healthy start, the opportunity to learn and protection from harm. The global Save the Children movement currently serves over 185 million children in the US and in more than 120 countries.
Miles joined the organization in 1998, was COO from 2004-2011, and became President and CEO in September 2011. Under her senior leadership, the organization has more than doubled the number of children it reaches with nutrition, health, education and other programs. Resources were just under $700m in 2015. Miles’ signature issues include hunger, learning outcomes, and ending preventable child deaths.
Prior to Save the Children, she worked in the private sector in Hong Kong for American Express and as an entrepreneur. While in Asia, she confronted the deprivation of the region’s children, which motivated her to dedicate her life to their welfare.
Miles has served on numerous boards, including Blackbaud, InterAction, USGLC, MFAN, Academy of Education, Arts and Sciences, and the University of Virginia’s Darden School of Business, where she received her MBA. In 2015, Miles was named one of the 50 World’s Greatest Leaders by Fortune magazine and inducted into the CT Women’s Hall of Fame. She is married with 3 children.
Dr. Olivia Namusisi Kasenge
Director of Programs, African Field Epidemiology Network (AFENET)
Olivia is the current Ag Executive Director of The African Field Epidemiology Network (AFENET). She also serves as the Director of Programs, a position she has held since 2008.
She has several years of experience working with applied epidemiology training programs in Africa, in epidemiological research, investigating and responding to epidemics, and implementing community-based interventions.
At AFENET, Olivia oversees 32 Member Countries and 16 Field Epidemiology and Laboratory Training Programs (FELTPS). She oversees all project activities, faculty, and mentors of FELTP residents among other duties.
AFENET was established in 2005 as a non-profit organization and networking alliance of African Field Epidemiology (and Laboratory) Training Programs (FELTPs), and other applied epidemiology training programs. AFENET is dedicated to helping ministries of Health in Africa build strong, effective, and sustainable programs with capacity to improve public health systems partnering with global public health experts. The network’s goal is to strengthen field epidemiology and public health laboratory capacity to contribute effectively to addressing epidemics and other major public health problems in Africa.
Baron Peter Piot
Director of the London School of Hygiene & Tropical Medicine
Handa Professor of Global Health
Baron Peter Piot, CMG, MD, PhD, is the Director of the London School of Hygiene & Tropical Medicine, and the Handa Professor of Global Health. He was the founding Executive Director of UNAIDS and Under Secretary-General of the United Nations (1995–2008), and was an Associate Director of the Global Programme on AIDS of the World Health Organization.
A clinician and microbiologist by training, he co-discovered the Ebola virus in Zaire in 1976, and subsequently led pioneering research on HIV/AIDS, women’s health and infectious diseases in Africa. He has held academic positions at the Institute of Tropical Medicine, Antwerp; the University of Nairobi; the University of Washington, Seattle; Imperial College London, and the College de France, Paris, and was a Senior Fellow at the Bill & Melinda Gates Foundation. He is a member of the US National Academy of Medicine, the National Academy of Medicine of France, and the Royal Academy of Medicine of his native Belgium, and is a fellow of the UK Academy of Medical Sciences and the Royal College of Physicians.
He is a past president of the International AIDS Society and of the King Baudouin Foundation. In 1995 he was made a baron by King Albert II of Belgium.
Professor Piot has received numerous awards for his research and service, including the Canada Gairdner Global Health Award (2015), the Robert Koch Gold Medal (2015), the Prince Mahidol Award for Public Health (2014), and the Hideyo Noguchi Africa Prize for Medical Research (2013), the F. Calderone Medal (2003), and was named a 2014 TIME Person of the Year (The Ebola Fighters). He has published over 580 scientific articles and 16 books, including his memoir, No Time to Lose.
Jeffrey L. Sturchio
President and CEO, Rabin Martin
Jeffrey L. Sturchio is president and CEO of Rabin Martin, a global health strategy firm. A respected global health thought leader, Dr. Sturchio is a trusted counselor to senior leaders in the private sector, multilateral organizations, governments, NGOs, and foundations. He has contributed to numerous publications in global health, most recently as co-editor of Noncommunicable Diseases in the Developing World: Addressing Gaps in Global Policy and Research (Johns Hopkins University Press). Previously, Sturchio was president and CEO of the Global Health Council, vice president of Corporate Responsibility at Merck & Co. Inc. and president of The Merck Company Foundation. Among his appointments, he currently serves as the chairman of the Corporate Council on Africa.
Chief Medical Officer, Global Public Health, Johnson & Johnson World Headquarters (US)
Trained as an infectious diseases physician, Dr. Alan Tennenberg brings over 20 years of experience in the pharmaceutical industry, clinical medicine, public health, and academia to the position of Chief Medical Officer of Johnson & Johnson Global Public Health. In this role he is responsible for building strategic relationships with key stakeholders and partners in government, academia, multi-lateral institutions, and non-governmental organizations around the world. He is a leading figure in facilitating private sector engagement to advance the Global Health Security Agenda.
President, Nigerian Academy of Science
Oyewale Tomori is the President of the Nigerian Academy of Science with experience in the area of virology, disease prevention and control. Dr. Tomori has served on numerous WHO advisory committees, among them WHO Africa Regional Polio Certification Committee, WHO Group of Experts on Yellow Fever Disease, and the International Steering Committee of the International Consortium on Anti-Virals, ICAV, Canada. In 1994, he was appointed as the Regional Virologist for the WHO Africa Region where he served for ten years, establishing the African Regional Polio Laboratory Network. In 2002 he received the Nigerian National Order of Merit, (NNOM), the country’s highest award for academic and intellectual attainment and national development, and in 1981 was recognized by the Center for Disease Control and Prevention for his contribution to Lassa Fever research. In October of 2016, Dr. Tomori was elected as an international member of the US National Academy of Medicine, an honor given to those who have demonstrated professional achievement and commitment to service, through their contributions to the field of medicine and public health. Dr. Tomori brings to the advisory committee extensive knowledge on viral infections, among them Lassa Fever, Yellow Fever, and Ebola Hemorrhagic Fever.
Dr. Yang Weizhong
Secretary General, Chinese Preventative Medicine Association
Biography coming soon.
Dr. Suwit Wibulpolprasert
Advisor, Ministry of Public Health, Thailand
In Thailand, Dr. Suwit has been the editor of a local journal for para-medical personnel and had produced radio and television programs on health and social issues for more than 15 years. He is currently the Advisor to the Ministry of Public Health on Global Health, the Chair of the Road Safety Foundation, the Social Well Being foundation; Board member of the Thailand the Health Systems Research Institute, the National Health Security Board, the National Nanotechnology Centre, the National Electronic and Computer Technology Center. Besides all these works, he has run 18 marathons. For international involvements, he represents Thailand in many international health forums and the World Health Assembly and its Executive Board. He also represented Thailand and the South- east Asia Region as a member and Vice Chair of the Governing Board of the Global Fund to Fight AIDS, TB, and Malaria in 2001-2004. He was the President of the Intergovernmental Forum on Chemical Safety in 2003-2006 and a member and Vice Chair of the WHO Executive Board during 2004-2007. He was the founder and first chair of Mekong Basin Disease Surveillance Network and the Asian Partnership on EIDs. He also chaired the Board of the Health Metrics Network in 2006-2007, and chair of the Asia Pacific Observatory in 2015-2016.